A phase II study of gemcitabine plus nab-paclitaxel as first-line therapy for locally advanced pancreatic cancer

Gemcitabine plus nab-paclitaxel (GnP) is widely used in clinical practice, despite a lack of prospective data to validate its efficacy in locally advanced pancreatic cancer (LAPC). We conducted a phase II study of GnP for LAPC to assess its efficacy and safety. We performed a single-arm, single-inst...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Fukahori, Masaru, Miwa, Keisuke, Murotani, Kenta, Naito, Yoshiki, Ushijima, Tomoyuki, Sakaue, Takahiko, Tanaka, Toshimitsu, Nagasu, Sachiko, Suga, Hideya, Kakuma, Tatsuyuki, Okabe, Yoshinobu, Torimura, Takuji
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2021
Assuntos:
5700
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8137062/
https://ncbi.nlm.nih.gov/pubmed/34011119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000026052
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados